Novo Nordisk launched a consumer campaign for Victoza, emphasizing the product’s ability to bring down blood sugar levels and body weight in patients with type 2 diabetes. The campaign features print ...
Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection). Liraglutide is a ...
Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes. Doctors also prescribe it to lower the risk of cardiovascular problems in people with both type 2 diabetes and heart failure ...
Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.
Saxenda and Victoza are brand-name injection pens that contain the same active drug, liraglutide. Saxenda is used for weight management. Victoza is used to treat type 2 diabetes and to lower the risk ...
PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza ® (liraglutide) to reduce the risk of major adverse cardiovascular ...
Indication(s): As adjunct to diet and exercise, to improve glycemic control in type 2 diabetes. The approval of Victoza in this patient population was based on data from the ELLIPSE trial which ...
BARCELONA—Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins. Ozempic (semaglutide) topped both SGLT2 drug Invokana from ...
Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback